Citation

Marchehi F, Travan L, Lazzerini M. Med. Bambino 2005; 24(6): 377-382.

Copyright

(Copyright © 2005, l'Associazione Culturale Pediatri, Publisher Edifarm)

DOI

unavailable

PMID

unavailable

Abstract

The increased use of antidepressant drugs in children and adolescents in the last years and the reports of suicides and self aggressive behaviours, especially among SSRI users, highlight the need for safety and efficacy evaluation of these drugs in younger patients. When choising the best depression treatment strategy, paediatricians and infantile neuropsychiatrists should consider several factors, such as age, access to care and familiar context.

Language: it

Keywords

Safety; human; age; pediatrics; systematic review; child; depression; aggression; randomized controlled trial; Suicide risk; Antidepressants; suicidal behavior; clinical trial; pediatrician; review; neuropsychiatry; treatment planning; fluoxetine; paroxetine; serotonin uptake inhibitor; sertraline; health care access; controlled clinical trial; medical decision making; drug choice; drug safety; drug efficacy; risk benefit analysis; Efficacy; drug screening; evidence based medicine; teamwork